Efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with B-cell non-Hodgkin lymphoma
BNT162b2 mRNA COVID-19疫苗在B细胞非霍奇金淋巴瘤患者中的疗效
期刊:Blood Advances
影响因子:7.1
doi:10.1182/bloodadvances.2021005094
Perry, C; Luttwak, E; Balaban, R; Shefer, G; Morales, M M; Aharon, A; Tabib, Y; Cohen, Y C; Benyamini, N; Beyar-Katz, O; Neaman, M; Vitkon, R; Keren-Khadmy, N; Levin, M; Herishanu, Y; Avivi, I